The Diabetic Technology Press by Alertgy
Alertgy Takes Top Prize International DxPx Conference Competition
Alertgy, a pioneer in 100% non-invasive continuous blood glucose monitoring won first place for the most disruptive medical technology in 2021 at a recently held DxPx Conference in Dusseldorf, Germany. Prior to this award, Alertgy secured top spot in DxPx’ North American competition. The prize, valued between $500,000 and $1,000,000 was sought by 237 applicants and 8 finalists globally.
Alertgy Welcomes Executive-Level Director of Engineering
Alertgy brings on two new acclaimed engineers to the team. We are happy to welcome Ben and Will to the team, and we are excited to see what the future holds.
Showcasing a Groundbreaking Possibility for Alertgy's Non-Invasive Propriety Sensor Technology for Detecting Covid-19
Alertgy is in the process of developing two key components to execute this research study- (1) an electret mask with a microfiber matrix to trap viral particles and (2) an in vitro dielectric analyzer unit, which includes Alertgy’s dielectric sensor and a custom-engineered reservoir for the real-time analysis of the microfiber matrix from the mask.
Alertgy Expands Into New Facility After Successful FlexTech Developer Partnership
Alertgy has expanded its capabilities with our new location expansion in Melbourne, Florida along with being awarded a Developers Agreement between Alertgy Inc. and SEMI Flex Tech.
Alertgy Awarded Patent US20200217809A1 Apparatus For In Vivo Dielectric Spectroscopy
Alertgy has been granted a patent for their innovative and groundbreaking radio frequency sensor technology. The awarded patent, Apparatus for in vivo dielectric spectroscopy (US20200217809A1), focuses on sensor technology that is 100% non-invasive and continuously monitors blood glucose in a way that does not involve blood oxidase, but rather dielectric spectroscopy and radio frequency.
What’s Next For The Biotech Startup Alertgy and Their Non-Invasive Glucometer
The biotech startup Alertgy has nearly completed the process of miniaturizing its first generation NICGM®, here’s what’s next for the non-invasive glucometer startup.
The New Med Tech Company That's Changing Glucose Sensor Technology
Alertgy is a cutting-edge biotech company working to revolutionize the way diabetics and pre-diabetics manage their diabetes. Alertgy has developed a technology that is unlike any other currently on the market.
What You Should Know About Alertgy's Deep-Gluco® AI driven Glucose Sensor
The Alertgy NICGM (Non-Invasive Continuous Glucose Monitor) is a one of a kind AI technology that gives diabetics and pre diabetics an easier, more cost efficient, and less painful way to monitor and manage their diabetes.
